Check out our most popular compounded medications! Get Started
Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredients over an extended period, providing sustained therapeutic effects. This formulation is used to treat symptoms of allergic rhinitis, sinusitis, nasal congestion, cough, and bronchitis. The slow release mechanism also reduces dosing frequency, thereby improving patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules is a compounded medication designed to alleviate symptoms associated with allergies, sinusitis, and nasal congestion. This formulation combines two active ingredients, brompheniramine maleate and pseudoephedrine hydrochloride, which synergistically work to provide relief from symptoms such as allergic rhinitis, sinusitis, nasal congestion, cough, and bronchitis.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for a gradual and sustained release of the active ingredients over an extended period of time. This slow release mechanism offers several benefits including prolonged therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Brompheniramine maleate, an antihistamine, functions by blocking the action of histamine, a chemical released by the body during an allergic reaction. This action helps to alleviate symptoms such as sneezing, itching, watery eyes, and runny nose. On the other hand, pseudoephedrine hydrochloride, a decongestant, works by constricting the blood vessels in the nasal passages. This reduces nasal congestion and facilitates easier breathing.
However, it is crucial to understand that this medication is not intended to treat the underlying conditions causing these symptoms. It should be used strictly as directed by a healthcare provider. If you have any questions or concerns about this formulation, it is recommended to consult with your healthcare provider or pharmacist.
This compounded formulation of Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules is designed to provide sustained therapeutic effects over an extended period of time. The capsules are formulated with Methocel E4M, a controlled-release polymer, which allows for a gradual release of the active ingredients. This slow release mechanism can lead to improved patient compliance due to reduced dosing frequency.
The formulation is indicated for the treatment of Allergic Rhinitis, Sinusitis, Nasal Congestion, Cough, and Bronchitis. However, it should not be used in patients with narrow-angle glaucoma, urinary retention, or severe hypertension. Caution is also advised for patients with cardiovascular disease, hyperthyroidism, diabetes, and prostatic hypertrophy. Furthermore, this formulation should not be used in patients who are currently taking monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants. Patients are also advised to avoid alcohol while taking this medication.
It's important to note that this formulation may interact with other medications, including but not limited to, anticholinergics, sympathomimetics, and other antihistamines. Therefore, patients should inform their healthcare provider of all medications they are currently taking prior to starting this formulation.
If you have any questions or concerns regarding this formulation, please do not hesitate to reach out for further information.
Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules is a compounded medication designed to alleviate symptoms associated with allergic rhinitis, sinusitis, nasal congestion, cough, and bronchitis. This combination medication works through the dual action of brompheniramine maleate and pseudoephedrine HCl. Brompheniramine maleate functions by inhibiting the effects of histamine, a substance in the body that triggers allergic symptoms. On the other hand, pseudoephedrine HCl operates by constricting the blood vessels in the nasal passages, thereby reducing congestion.
The unique feature of this medication is its slow-release capsule formulation, which incorporates Methocel E4M, a type of controlled-release polymer. This design ensures a gradual and sustained release of the active ingredients over an extended period. This slow-release mechanism offers several benefits, including sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
When using Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules, it is crucial to adhere to the instructions provided by your healthcare provider or pharmacist. The capsules should be consumed with food or a full glass of water to minimize the possibility of stomach upset. Consistency in the timing of medication intake each day is essential to ensure steady symptom relief. It is also vital to avoid exceeding the recommended dose to prevent the risk of potential side effects.
If you have any queries or require further information about Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules, please do not hesitate to contact us. We are committed to helping you understand the workings of this medication and how it can assist in managing your symptoms effectively.
This compounded formulation of Brompheniramine Maleate 8 mg/Pseudoephedrine HCl 120 mg Slow Release Capsules is designed with Methocel E4M, a controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This formulation is particularly beneficial for medications requiring a controlled and prolonged release profile.
It is used to treat a variety of conditions including allergic conjunctivitis, urticaria, and pruritus. Additionally, this formulation can be used to alleviate symptoms of hay fever, including itchy eyes, sneezing, and nasal congestion.
Furthermore, it can be used to treat symptoms of upper respiratory tract infections, such as sore throat, cough, and nasal congestion. It is also beneficial in managing symptoms of bronchitis, including chest congestion, cough, and difficulty breathing. It is crucial to understand that this formulation should not be used to treat any condition other than those specified above. For any queries regarding the use of this formulation, it is recommended to consult with a healthcare professional.
This is a compounded medication that contains Brompheniramine Maleate and Pseudoephedrine HCl. It is formulated in a slow-release capsule form, designed to gradually release the medication over an extended period of time for sustained therapeutic effects.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to gradually release the encapsulated medication over an extended period of time, offering sustained therapeutic effects and improved patient compliance.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects over an extended period of time, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
As this is a slow-release formulation, the frequency of dosing is typically less than with immediate-release medications. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
Brompheniramine Maleate is an antihistamine used to relieve symptoms of allergies and the common cold. Pseudoephedrine HCl is a decongestant used to relieve nasal congestion. The combination of these two active ingredients can effectively relieve symptoms such as runny nose, sneezing, and congestion.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Common side effects may include dizziness, dry mouth/nose/throat, nausea, or trouble sleeping. If any of these effects persist or worsen, notify your healthcare provider promptly.
Before taking this medication, tell your healthcare provider if you are pregnant or breastfeeding. The effects of this medication on an unborn baby or nursing infant are not fully known, so it should be used only when clearly needed and as directed by a healthcare provider.
Before starting this medication, tell your healthcare provider about all the products you use, including prescription drugs, nonprescription drugs, and herbal products. Some products may interact with this medication, affecting how it works or increasing the risk of side effects.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
